guia de boston inglés

2011 REVIEW OF CLINICAL RESEARCH & INNOVATIONSA GUIDE TO THE AMERICAN ACADEMY OF OPTOMETRY POSTERS AND PRESENTATIONS

40038_AbstractBook 1 8/24/11 3:52 PM40038_AbstractBook_Hi.pdf 140038 AbstractBook Hi.pdf 1 10/26/11 6:01 AM10/26/11 6:01 AM

4

The world’s fi rst disposable contact lens ACUVUE® Brand Contact Lenses changed contact lenses forever.

The world’s fi rst daily disposable contact lens1-DAY ACUVUE® Brand Contact Lenses bring comfort and convenience to millions of wearers.

PUPIL INTELLIGENT DESIGN™ ACUVUE® Brand Contact Lenses BIFOCAL feature unique technology that corrects presbyopia.

HYDRACLEAR®TechnologyACUVUE® ADVANCE® Brand Contact Lenses with HYDRACLEAR® Technology off er exceptional long-lasting comfort.

BLINKSTABILIZEDTM

TechnologyACUVUE® ADVANCE® Brand Contact Lenses for ASTIGMATISM provide a predictable, stable lens.

Introducing...HYDRACLEAR® Plus TechnologyACUVUE® OASYS® Brand Contact Lenses with HYDRACLEAR® Plus are designed to provide comfort in dry, challenging environments.


5

STEREO PRECISION TECHNOLOGY™ optical design ACUVUE® OASYS® Brand Contact Lenses for PRESBYOPIA provide balanced vision for near, far and in-between.

2006

LACREON®Technology 1-DAY ACUVUE® MOIST® Brand Contact Lenses give a fresh new comfortable feeling from morning to night.

The world’s fi rst daily disposable silicone hydrogel 1-DAY ACUVUE® TruEyeTM Brand Contact Lenses. World’s fi rst daily disposable silicone hydrogel. (Note: Launched outside the US in 2008.)

BLINK STABILIZED™TechnologyACUVUE® OASYS® Brand Contact Lenses for ASTIGMATISM provide a predictable,stable lens.

HYDRACLEAR® Technology With enhanced technology, ACUVUE® ADVANCE® Plus Brand Contact Lenses off er exceptional comfort and performance in a fresh, 2-week modality.


6

Professional Development& Medical Aff airsProfessional Development & Medical Aff airs at VISTAKON® Division of Johnson & Johnson Vision Care, Inc. continues to serve as the voice of our professional customer within our organization and is responsible for delivering technical, clinical, and educational support to the profession. Professional Development & Medical Aff airs is committed to establishing enduring partnerships with optometry students, doctors, and professional organizations through innovative education and training.

The team’s broad range of experience encompasses publishing clinical articles, presenting at symposia, and involvement in optometric education. This experience, as well as their commercial backgrounds from franchise directors to independent practice owners, helps them to provide a broad perspective from which they can draw when meeting fellow professionals.

Since its inception in 2004, THE VISION CARE INSTITUTE™ has provided additional training to 1 in 5 practicing US optometrists. Our mission is to enhance patient satisfaction through innovative education for all eye care providers. We look to foster confi dence in proactively providing vision care to your patients through comprehensive technical training and unique hands-on patient interaction.

THE VISION CARE INSTITUTE™ is a state-of-the-art facility located in Jacksonville, Florida that welcomes optometry students and practicing eye care professionals from all over North America.

If you would like to register for one of our classes, visit www.tvciedu.com or speak with your local VISTAKON® sales representative.

Colleen M. Riley, OD, MS, FAAOVice President, Professional Development & Medical Aff airs

Dr. Colleen Riley is the Vice President of Professional Development & Medical Aff airs for VISTAKON® Division of Johnson & Johnson Vision Care, Inc. Dr. Riley leads the team that provides scientifi c and clinical expertise and focuses on professional development and support for eye care professionals. She also oversees the strategies and activities for THE VISION CARE INSTITUTE™, LLC, which provides innovative clinical, technical, and practice education. Dr. Riley joined the Research and Development team at VISTAKON® in 2004, where she played an essential role in all stages of product development. Most recently she served as Director of Design, Research and Development. Dr. Riley received her Doctor of Optometry degree along with a Master of Science in Physiological Optics from Indiana University School of Optometry. She began her career path in practice and as a faculty member at Indiana University. She is a Fellow and a Contact Lens Diplomate in the Section on Cornea, Contact Lenses and Refractive Technologies of the American Academy of Optometry, and served as a Principal Investigator in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study funded by the National Eye Institute. An accomplished speaker and author, Dr. Riley was selected as one of the Top 20 Most Infl uential Women in the Optical Industry in 2007.

THE VISION CARE INSTITUTETM


7

Sheila B. Hickson-Curran, BSc (Hons), MCOptom, FAAO, FBCLA Director, Medical Aff airs

Sheila Hickson-Curran earned her optometry qualifi cations from the City University, London, United Kingdom. Sheila joined VISTAKON® in 1995 as a Research Optometrist, with positions of increasing responsibility in Research & Development. She is the co-inventor of BLINK STABILIZEDTM Technology, used in ACUVUE® ADVANCE® Brand Contact Lenses for ASTIGMATISM and ACUVUE® OASYS® Brand Contact Lenses for ASTIGMATISM, for which she won a Johnson Medal, the highest award for innovation in Johnson & Johnson. In her role as Director of Medical Aff airs, she provides technical education for our professional customers, as well as professional insight and counsel for Brand teams. Sheila is a Fellow of the American Academy of Optometry.

Cristina M. Schnider, OD, MSc, MBA, FAAOSenior Director of Medical Aff airs

Dr. Cristina Schnider is Senior Director of Medical Aff airs for VISTAKON® Division of Johnson & Johnson Vision Care, Inc. From 2007 to late 2010, Dr. Schnider led the Professional and Medical Aff airs team for Johnson & Johnson Vision Care Company in Japan. Dr. Schnider joined VISTAKON® in 1999, following a 14-year career in academia, with positions at the State University of New York College of Optometry, the Cornea & Contact Lens Research Unit in Sydney, Australia, and Pacifi c University College of Optometry. Dr. Schnider received her Doctor of Optometry degree from Pacifi c University College of Optometry, a Master of Science in Clinical Research from the University of New South Wales in Australia, and an MBA from the University of Florida. She is a Fellow, a Contact Lens Diplomate, and a member of the leadership team in the Section on Cornea, Contact Lenses and Refractive Technologies of the American Academy of Optometry, a council member for the International Society for Contact Lens Research, and has spoken and published in several languages on topics related to cornea and contact lenses.

Arthur Shedden, MD, MBADirector of Medical Aff airs and Medical Safety Offi cer

Art Shedden, MD, is Director of Medical Aff airs and Medical Safety Offi cer of VISTAKON® Division of Johnson & Johnson Vision Care, Inc. Dr. Shedden earned his medical degree from Jeff erson Medical College in Philadelphia, PA. He completed his residency in ophthalmology at the University of Pittsburgh in Pittsburgh, PA and his fellowship in neuro-ophthamology at the Bascom Palmer Eye Institute at the University of Miami in Miami, FL. He earned his MBA from the Wharton School of Business at the University of Pennsylvania in Philadelphia, PA. Dr. Shedden has led teams in clinical development for ophthalmology at Merk Research Laboratories and in global medical aff airs for ophthalmology at Pfi zer/Pharmacia. Prior to joining VISTAKON® in 2008, he managed global medical aff airs for allergy and respiratory at Schering-Plough.


8

Richard Wallingford, Jr, OD, FAAO Director, Professional Aff airs

Dr. Richard Wallingford is Director of Professional Aff airs at VISTAKON® Division of Johnson & Johnson Vision Care, Inc. He is a past President of the American Optometric Association, serving as the President from 2005-2006. He is also the past President of the Maine Optometric Association and past President of the Maine Board of Optometry, serving eleven years by the Governors appointment. Dr. Wallingford served on an AOA committee or board continuously for 28 years.

A graduate of the New England College of Optometry, he served on their Board of Trustees for over 8 years. He is a member of the Governing Board and the Treasurer of the World Council of Optometry, and the World Optometry Foundation. He is also the Past President of the Partnership Foundation for Optometric Education. Dr. Wallingford has been in a private practice, a partnership specializing in contact lenses, and a large OD/MD practice with two ambulatory surgical suites and a Lasik center, all located in Maine. Over the years, Dr. Wallingford has received numerous awards, but none as special as the Lifetime Distinguished Service Award from the Maine Optometric Association in 2006.

Katie Carpenter, MBASenior Director, THE VISION CARE INSTITUTE™, LLC

Katie is Senior Director of THE VISION CARE INSTITUTE™, LLC. She also serves as General Manager, leading strategic planning, curriculum development, and alumni relations. Prior to coming to VISTAKON®, Katie worked in marketing for AstraZeneca Pharmaceuticals in the Respiratory and Oncology therapeutic areas. Prior to AstraZeneca, Katie worked for the Veterinary Pharmaceutical division of Pfi zer, Inc. in marketing their antibiotic and equine portfolios along with the launch of Anipryl™.* She has also worked at several advertising agencies in the Philadelphia area for such clients as Alpo Pet Foods, Scott Paper Company, The Iams Company, Tastykake Baking Company, Sunoco Oil, and the City of Philadelphia. Katie has her MBA from Pennsylvania State University and a BS in Communications from the University of Miami, Florida.

Aaron See, MBADirector, Professional Development & Education

Aaron See is the Director of Professional Development & Education for VISTAKON® Division of Johnson & Johnson Vision Care, Inc. He has over 12 years of experience in the Global Health Care arena, where he has focused on bridging the opportunities and needs of patients and professionals. Over this time, he has worked extensively across Asia, Europe, and the Americas in the areas of analgesics, cardiovascular, and vision care. Most recently, Aaron led the Johnson & Johnson Vision Care, Inc. global introduction of 1-DAY ACUVUE® TruEye™ Brand as the world’s fi rst daily disposable silicone hydrogel lens. Aaron is a graduate of Brandeis University with a BA in economics & international relations. He earned his Masters of Management degree from JL Kellogg Graduate School of Management, with majors in marketing, management & strategy, and entrepreneurship.


9

Giovanna E. Olivares, OD, FAAODirector of Professional Education

Dr. Olivares is the Director of Professional Education at VISTAKON® Division of Johnson & Johnson Vision Care, Inc. In this role, she is responsible for the development of new and innovative educational professional programs. Dr. Olivares graduated from the State University of New York with a doctorate degree and subsequently completed a post-doctoral fellowship program in ocular disease management in affi liation at the State University of New York College of Optometry. Upon completion of her fellowship, she became an Assistant Professor at the College of Optometry, having responsibility in both didactic and clinical programs. Following her academic career, she joined Unilens Corp. USA as the Director of Professional Development and Clinical Aff airs, and spent 12 years developing new presbyopic contact lenses. In 2004 she joined VISTAKON®. As the Senior Manager of Clinical Research, she led a multidisciplinary group of optometrists, biostatisticians, and vision scientists that were responsible for the development of new contact lens products such as ACUVUE® ADVANCE® for ASTIGMATISM, ACUVUE® OASYS® for ASTIGMATISM, ACUVUE® ADVANCE® Plus, and other products that have been launched throughout the world. Dr. Olivares is a Fellow of the American Academy of Optometry

Carol Alexander, OD, FAAODirector of Professional Aff airs

Dr. Carol Alexander is Director of Professional Aff airs for VISTAKON® Division of Johnson & Johnson Vision Care, Inc. She is responsible for the VISTAKON® Professional Aff airs Consulting Team (PACs), bringing the Innovation for Healthy VisionTM campaign to practitioners through a series of peer-to-peer programs. Her primary role is to serve as liaison between the optometric community and the internal teams at VISTAKON®. In her position, she provides valuable insight regarding the mindset of the practitioner, having been in private practice for 21 years in northwest Ohio. Dr. Alexander joined VISTAKON® in 2007 and is a 1987 graduate of The Ohio State University College of Optometry. Her previous leadership roles include the Presidency of the Ohio Optometric Association and chairperson for the AOA’s Commission on Quality Assurance and Improvement. She has been honored with the AOA’s Young Optometrist of The Year Award, and subsequently with Ohio’s Optometrist of The Year Award. Dr. Alexander is a member of the California and American Optometric Associations and is a Fellow of the American Academy of Optometry. In 2010 she was named one of Vision Monday’s Most Infl uential Women in Optical.


10

W. Lee Ball, Jr., OD, FAAOAssociate Director of Medical Aff airs

W. Lee Ball, Jr., OD, is Associate Director of Medical Aff airs of VISTAKON® Division of Johnson & Johnson Vision Care, Inc. Dr. Ball holds a degree in Public Health from the University of North Carolina at Chapel Hill, is a graduate of the University of Houston College of Optometry, and a Fellow of the American Academy of Optometry. He completed his Optometric residency at the University of Miami Bascom Palmer Eye Institute. After residency, Dr. Ball joined the staff s at Beth Israel Deaconess Medical Center and Joslin Diabetes Center, teaching hospitals of Harvard Medical School. Before joining VISTAKON®, Dr. Ball was an adjunct clinical faculty member at the New England College of Optometry. He is past chair of the Pharmacy, Podiatry, Optometry and Dental Health Provider (PPOD) work group for the National Diabetes Education Program (NDEP) and was named the Massachusetts Young Optometrist of the Year for 2010.

Janelle Routhier, OD, FAAOManager of Medical Aff airs

Dr. Janelle Routhier earned her doctorate of Optometry from the Michigan College of Optometry at Ferris State University in 2008 and went on to complete a Cornea and Contact Lens residency at Michigan College of Optometry. She joined the VISTAKON® team in early 2011. In her role as Manager, Medical Aff airs, she is responsible for providing clinical and technical insight to the company and to professional prescribers of VISTAKON® products. Previously, Dr. Routhier was contact lens clinical faculty at Michigan College of Optometry and also worked in private practice. She has developed and performed research in the area of toric orthokeratology and is also a Fellow of the American Academy of Optometry. She was recently named one of the fi rst Diplomates of the America Board of Optometry in the country, after completing the board certifi cation process in August, 2011.

Maggie Boniecka, BSAssociate Product Director, THE VISION CARE INSTITUTE™, LLC

Maggie Boniecka is Associate Product Director for THE VISION CARE INSTITUTE™, LLC. In this role she is responsible for leading strategic communication initiatives for alumni of the Institute as well as managing the Alumni Community. Prior to her current role, Maggie led professional digital marketing eff orts at VISTAKON®. She also spent time at Force 3, Inc., an IT solutions company, developing recruitment and engagement programs for potential customers. Maggie graduated Cum Laude from the University of Maryland, Robert H. Smith School of Business with a BS in Marketing.

40038_AbstractBook 10 8/26/11 11:58 AM40038_AbstractBook_Hi.pdf 1040038 AbstractBook Hi.pdf 10 10/26/11 6:01 AM10/26/11 6:01 AM

Focused on everyone’s vision but your own? Instead of spending all day working in your practice, let’s spend some

critical time working on it. With ODLean’s guidance, you’ll be empowered to work more productively and profitably. To find

out what this means to your practice, call us today.


12

Carol Lakkis, BScOptom, PhD, PGCertOcTher, FAAO, FVCO, FBCLAFrank Anastasopoulos, MSc; Jared Slater, BScOptom; Brian Pall, OD, MS

PURPOSE: To assess the clinical and subjective performance of silver salt-infused silicone hydrogel lenses compared to standard silicone hydrogel lenses over six months of daily wear.

METHODS: A prospective, randomised, double-masked, contralateral study was conducted. Sixty subjects were randomly assigned to wear silver salt-infused (galyfi lcon A with incorporated silver iodide, test) and standard (galyfi lcon A, control) silicone hydrogel CLs on a contralateral basis for six months of daily wear. Study visits were conducted at 1 week, 4 weeks, 3 and 6 months following lens delivery, and included assessment of a range of objective and subjective clinical performance measures.

RESULTS: Fifty subjects completed the study. There were no discontinuations due to adverse events and no signifi cant diff erences in adverse response rates between the test and control eyes (P>0.05). The test lenses did not aff ect high or low contrast visual acuity, or subjective vision or comfort ratings compared to the control lenses (P>0.05). No silver deposition in the cornea or tissue colour changes were noted in any subject and no statistically signifi cant diff erences between test and control lens wearing eyes were observed for all ocular health measures (P>0.05). Some signifi cant changes over time were observed in bulbar and limbal redness (P<0.05), corneal and conjunctival staining (P<0.05) and intraocular pressure (1 mmHg decrease, P<0.05) with both lens types; however, these were not considered to be clinically signifi cant.

CONCLUSIONS: The silver salt-infused test and control lenses performed similarly with respect to visual acuity, ocular health measures and subjective ratings when worn over six months of daily wear.

Dr. Carol Lakkis completed her Bachelor of Science in optometry and PhD degrees at the University of Melbourne in 1991 and 1999, respectively. She then moved to the University of California, Berkeley, School of Optometry where she held the titles of Assistant Clinical Professor and Research Scientist. Dr. Lakkis was then appointed as Director of Research of Clinical Vision Research Australia, at the Australian College of Optometry from 2002 to 2010. In August 2010 Dr. Lakkis joined VISTAKON® Division of Johnson & Johnson Vision Care, Inc. in the USA as a Clinical Research Fellow, and continues her work with Queensland University of Technology as an Adjunct Associate Professor.

Study supported by VISTAKON® Division of Johnson & Johnson Vision Care, Inc.

Galyfi lcon A lens formulation without (left) and with infused silver (right), challenged with Staphylococcus aureus

PRESENTATIONClinical Performance of Silver Salt-Infused Silicone Hydrogel Contact Lenses over Six Months of Daily Wear

OCTOBER 12Room 3113:30 PM


13

ONE YEAR PHYSIOLOGY DATA KEY MEASURES

LOWER MARGIN UPPER MARGIN

Cornea Vascularization

Conjunctival Hyperemia

Limbal Hyperemeia

Corneal Staining

Conjunctival Staining

Papilary Conjuctivitis

Spectacles Better TruEyeTM (nara B) Better

-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0


Jason J. Nichols, OD, MPH, PhD, FAAO, is a Professor at the University of Houston College of Optometry, where he is responsible for teaching coursework on the tear fi lm, dry eye, corneal physiology and contact lenses. He has received research funding from the National Eye Institute of the National Institutes of Health to study dry eye diseases including meibomian gland disease, dry eye and contact lens-related dry eye. He has also received funding from the American Optometric Foundation, in addition to a variety of industrial partners. He has authored over 70 peer-reviewed manuscripts and 130 abstracts on these topics. He is currently Editor of Contact Lens Spectrum, serves on the editorial board for Eye and Contact Lens and is also a diplomate in the American Academy of Optometry’s sections of Public Health and Environmental Optometry and Cornea, Contact Lenses, and Refractive Technology.

Jason J Nichols, OD, MPH, PhD, FAAO, Diplomate, Contact Lens and Public HealthKathrine E Osborn, OD, MS, FAAO, FBCLA; Terri Henderson, MS; Jeff rey J Walline, OD, PhD, FAAO

PURPOSE: To compare the physiological response of the eye to daily disposable silicone hydrogel contact lens wear in neophytes over a one year period.

METHODS: This was a randomized, masked clinical trial. At baseline, neophyte subjects between 15 and 39 years of age, with a distance contact lens correction between -0.50 and -6.00 DS and less than 0.75 DC were randomly assigned to 1-DAY ACUVUE® TruEyeTM Brand Contact Lenses (narafi lcon B, Johnson & Johnson Vision Care, Inc.) (n = 47) or to continue wearing their own spectacles (n = 47). After randomization, subjects were evaluated at fi ve additional visits occurring at 10 days (visit 2), one month (visit 3), 3 months (visit 4), 6 months (visit 5), and one year (visit 6). Among other outcomes, subjects were evaluated for ocular physiological changes using slit-lamp biomicroscopy and the Efron grading scales with responses graded from zero to four. A linear mixed model with group and visit as fi xed eff ects and patient as a random eff ect was used to analyze the data using SAS 9.2.

RESULTS: Ninety four subjects were randomized (average age = 22.9 years, 50% female), and 74 subjects completed the one-year follow-up. For papillary conjunctivitis, conjunctival hyperemia, limbal hyperemia, and corneal vascularization, the contact lens and spectacle groups were equivalent through the year long period. For corneal staining, the contact lens and spectacle groups were equivalent across the year-long period, with the exception of the last visit, at which the contact lens wearers had signifi cantly more corneal staining (mean diff erence = 0.39 units, 95% CI = 0.15 to 0.64). Contact lens wearers had higher average conjunctival staining at most follow-up visits ranging in diff erence from 0.30 to 0.91 units. There were no instances of any serious, signifi cant, or corneal infi ltrative events in either group.

CONCLUSION: For neophyte subjects wearing a daily disposable, silicone hydrogel contact lens, the physiological response of the eye is comparable to wearing spectacles, with the exception of increased conjunctival staining.

PRESENTATIONOne Year Follow-up of Daily Disposable Silicone Hydrogel Lens Wear vs Spectacle Wear in Neophytes



14

Study sponsored by VISTAKON® Division of Johnson & Johnson Vision Care, Inc.

Terri L Henderson, MS RJ Wirth, PhD; Michael L Henderson, MS; Colleen M Riley, OD, MS, FAAO

PURPOSE: To describe the evidence supporting content validity for the patient-reported outcomes (PRO) instrument CLUE: Contact Lens User Experience™.

METHODS: The FDA guidance and NIH roadmap initiative Patient-Reported Outcomes Measurement Information System (PROMIS) were maps for building a measurement framework. Development involved collecting patient input and satisfying saturation of the patient experience with soft, disposable contact lenses. Cognitive interviews built knowledge of patient experiences. Patient focus groups covered age ranges and lens types. An initial item bank was tested with psychologist-led interviews and fi nalized with instructions, recall periods and response scales. The item bank was validated in 4 phases on 1486 subjects.

RESULTS: Pre-testing led to qualitatively-recommended maximum duration of 10 minutes. Fundamental questions on response options wording and polarity of item wording were addressed. Agreement and frequency response options were tested and frequency showed a 20% lower reliability and 10% increase in standard error (SE) over the population range. Items worded both positively and negatively demonstrated a 26% reduction in reliability if negative with a 13% increase in SE. A novel approach used adjectives to modify wording strength of item stems and indicated increases in measurement capability at the extremes of patient experiences. Modifying base items with “very” demonstrated a twofold increase in reliability for the top 2.5% of the population and a 99-fold increase from base to “extremely”.

CONCLUSIONS: Through a series of rigorous experimental stages, the evidence supporting content validity of CLUETM is mapped out. The tool is optimal for use on the intended population and meets the criteria for saturation by covering the scope of everyday life with lenses. CLUETM is a true PRO instrument whose content captures the lens experience directly from the patient’s perspective.

TEST INFORMATION FUNCTION USING MODIFIERS

RELIABILITY CHANGES USING MODIFIERS

3.0

2.5

2.0

1.5

1.0

0.5

0.00 20 40 60 80 100 120

BASE VERSION“VERY” VERSION“EXTREMELY” VERSION

CLUETM Score

Info

rmat

ion

1.0

0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0.00 20 40 60 80 100 120

BASE VERSION“VERY” VERSION“EXTREMELY” VERSION

CLUETM Score

Rel

iab

ility

PRESENTATIONDemonstrating Content Validity of CLUE: Contact Lens User ExperienceTM


Terri Henderson is a Senior Biostatistician/Patient-Reported Outcomes Lead at VISTAKON® Division of Johnson & Johnson Vision Care, Inc. She has provided biostatistics support for numerous launches of ACUVUE® Brand Contact Lenses for the past 6 years. In addition, she leads the patient-reported outcomes initiative at JJVCI, including publication plans regarding the development of CLUE: Contact Lens User Experience™, expansions and new clinical study questionnaire development.


15

Michael L Henderson, MS RJ Wirth, PhD; Terri L Henderson, MS; Kathrine Osborn, OD, MS, FAAO, FBCLA

PURPOSE: To demonstrate whether patients’ speed of responding to questionnaires is impacted by the length of the instrument. Item response theory (IRT) based scores and standard errors from the patient-reported outcomes (PRO) instrument CLUETM: Contact Lens User Experience™ will be evaluated when increasing the number of questions within domains.

METHODS: Data was collected via electronic data capture (EDC) from the patient using a kiosk designed for in-offi ce. Four fi xed forms were 81 and 85 items in length with 140 unique items. Patients answered an average of 80.9 items. There were a total of 28 comfort items per form, 34 or 40 vision items, 10 or 11 handling items and 7 or 8 packaging items. The EDC system captured the time a patient responded to an item in seconds. The time to answer an item was calculated as the time since responding to the previous item. IRT scores and standard errors were calculated as cumulative scores incorporating each additional item answered. The change in IRT score from the previous cumulative score was calculated to evaluate convergence.

RESULTS: 470 patients completed the questionnaire per protocol and three completed two questionnaires at the baseline visit. Patients spent an average of 12 seconds getting to the second item. The time to answer decreased (ie, speed up) until the 15 to 20th item, possibly due to screen clicking, and took an average of 2 minutes to reach this point. The change in cumulative IRT scores from the previous score for comfort converged after 8-10 items. The other domains had similar results.

CONCLUSIONS: A maximum of ten items is usually suffi cient to obtain accurate IRT scores from a fi xed instrument while the “uncertainty” (ie, standard error) increases. To ensure obtaining reliable information, the questionnaire should have the minimum number of items to obtain an accurate score, which could be obtained by extending to computer-adaptive IRT methods.

100

90

80

70

60

50

40

30

20

10

0

TIME TO ANSWER vs CUMULATIVE TIME SPENT ON FORMTIME TO ANSWER < 100 (38,035 EXCLUDING 17 DATA POINTS)

Tim

e to

Ans

wer

(se

cond

s)

Cumulative Time (seconds)

0 200 400 600 800 1000 1200 1400 1600 1800


Impact of Questionnaire Length on Quality of Responses

OCTOBER 12Room 3114:45 PMPRESENTATION

Michael Henderson is the Manager of Biostatistics for VISTAKON® Division of Johnson & Johnson Vision Care, Inc. based in Jacksonville, Florida. He has over 10 years of experience with the design and analysis of clinical trials for contact lens development. Over this time, he has worked extensively with the science of patient-reported outcomes including the development of new survey instruments for contact lens users. He has a BS in Mathematics and MS in Statistics from the University of Georgia.


16

Patient Age and Compliance with Contact Lens Hygiene, Lens Case Replacement and HygieneSheila Hickson-Curran, BSc(Hons), MCOptom, FAAO, FBCLA Robin L Chalmers, OD, FAAO

PURPOSE: To report the association between patient age and self-report of attitudes and compliance with steps in contact lens hygiene, and cleaning and replacement of lens storage cases.

METHODS: A masked internet survey of 787 soft reusable contact lens (CL) wearers was conducted in the USA that questioned respondents about their habits and practices regarding storage case hygiene practices and replacement frequency. Self-report of agreement with statements (“strongly” or “somewhat agree”) was analyzed across age groups (18-24 years, 25-29 years, 30-34 years and 35-39 years) by Fisher’s Exact Test, with p<0.05 considered signifi cant. For replacement questions the median reported frequency is reported for each age group.

RESULTS: Respondent’s mean age was 29.3 yrs, 78% were female and 83% Caucasian. Age groups were comprised of 160 aged 18-24 years, 146 aged 25-29 years, 191 aged 30-34 years and 136 aged 35-39 years. Age was a signifi cant factor in the report of hand washing before handling CLs (65.6% of 18-24 year olds vs 86.0% of 35-39 year olds, p 0.0001); cleaning CLs only when they irritate the eyes (37.5% of 18-24 year olds vs 20.6% of 35-39 year olds, p=0.016); being afraid that rubbing CLs will damage them (50.0% of 18-24 year olds vs. 39.7% of 35-39 year olds, p=0.019) and knowing they could do a better job of taking care of CLs (63.8% of 18-24 year olds vs 51.4% of 35-39 year olds, p=0.03). The median replacement frequency of CL storage cases was once per year for 18-24 year olds vs. once every 4-6 months for other age groups. Median frequency of CL case cleaning was once per week for 18-24 year olds and 2-3 times per week for other age groups.

CONCLUSIONS: Young CL wearers reported signifi cant diff erences in their CL hygiene attitudes and behaviors and reported less frequent cleaning and replacing their CL cases. Specifi c, clear and repeated instructions should be tailored for the young adult contact lens wearer.


PRESENTATIONOCTOBER 13

Room 31111:15 AM

Sheila Hickson-Curran earned her optometry qualifi cations from the City University, London, United Kingdom. Sheila joined VISTAKON® in 1995 as a Research Optometrist, with positions of increasing responsibility in Research & Development. She is the co-inventor of BLINK STABILIZEDTM Technology used in ACUVUE® ADVANCE® for ASTIGMATISM and ACUVUE® OASYS® for ASTIGMATISM, for which she won a Johnson Medal, the highest award for innovation in Johnson & Johnson. In her role as Director of Medical Aff airs, she provides technical education for our professional customers, as well as professional insight and counsel for Brand teams. Sheila is a Fellow of the American Academy of Optometry.


17

Patient Compliance: Is an Electronic Reminder System Eff ective When it Comes to Replacing Contact Lenses as Directed?Janelle Routhier, OD, FAAORoyce Carvalho, MBA; Elizabeth Kreul-Starr, JD, MBA

PURPOSE: Patient compliance with their doctor’s recommended contact lens replacement schedule is topical, but strategies to improve compliance have not been investigated. This poster presents data on the eff ectiveness of an electronic reminder system for patients wearing biweekly and monthly replacement lenses.

METHODS: A targeted sample of 14,429 US contact lens wearers enrolled in an electronic reminder system were invited to participate in an online survey. Out of that target population, those who agreed to participate (n=620), answered questions regarding the use of the reminder system to help replace their contacts on time.

RESULTS: For patients who adopted the use of the reminder system, compliance with their doctors’ recommended replacement schedule increased from 40% to 77%. Ninety-fi ve percent of the enrollees found it to be useful, while 66% believed the program changed their lens replacement behavior. Before using a reminder system, the average replacement frequency for biweekly replacement was 19.9 (±12.7) days and 35.6 (±17.6) days for monthly. After using an electronic reminder, biweekly replacement was averaged 14.7 (±3.6) days. The average for monthly replacement was 30.0 (± 6.0) days. Ninety percent agreed that the reminder system made remembering to change their lenses much easier. Reminder by email was the most popular, at 93%.

CONCLUSIONS: This survey revealed that using an electronic reminder system helped patients to change their contacts in accordance with their doctors’ recommended replacement frequency. It also reported that patients found value in having a reminder to change their lenses. In addition, patient wearing behavior was positively impacted as result of the prompts. This tool was benefi cial to all replacement frequencies, increasing compliance with their doctor’s recommendation from 40% to 77%. To help keep patients on track amidst their busy lives, something as simple as an electronic reminder may be the key to compliance not only for contact lenses, but for the medical industry in general.

80%

70%

60%

50%

40%

30%

20%

10%

0%<14 Days

14 Days

15-18Days

19-21Days

>21 Days

TWO WEEK REPLACEMENTPrior to & After Use of Reminder

N=533

PRIORAFTER

Prior average=19.9 DaysAfter average=14.7 Days

80%

70%

60%

50%

40%

30%

20%

10%

0%<30 Days

30 Days

31-45Days

46-60Days

>60Days

MONTHLY REPLACEMENTPrior to & After Use of Reminder

N=533

PRIORAFTER

Prior average=35.6 DaysAfter average=30.0 Days


OCTOBER 13Room 31111:45 AMPRESENTATION

Dr. Janelle Routhier earned her doctorate of Optometry from the Michigan College of Optometry at Ferris State University in 2008 and went on to complete a Cornea and Contact Lens residency at Michigan College of Optometry. She joined the VISTAKON® team in early 2011. In her role as Manager, Medical Aff airs, she is responsible for providing clinical and technical insight to the company and to professional prescribers of VISTAKON® products. Previously, Dr. Routhier was contact lens clinical faculty at Michigan College of Optometry and also worked in private practice. She has developed and performed research in the area of toric orthokeratology and is also a Fellow of the American Academy of Optometry.


18

Harold E. Bedell, PhD, FAAOAmber Gaume Giannoni, OD, FAAO; Saumil S. Patel, PhD; Katrina E. Parker, OD, FAAO; Norman E. Leach, OD, MS, FAAO; Anita Ticak, OD, MS and Ashley Wallace-Tucker, OD

PURPOSE: Subjects exposed to blurred visual stimuli are reported to undergo adaptation, such that the blurred stimuli gradually appear less blurred. We examined whether presbyopic subjects adapt to the combination of blurred and clear images that are produced by simultaneous-vision contact lens (CL) correction when worn during a trial period.

METHODS: Blur-detection and blur-acceptance thresholds were determined in 13 subjects, aged 41-56 years, before being fi tted with ACUVUE® OASYS® Brand Contact Lenses for PRESBYOPIA concentric bifocal contact lenses and after a 1-2 week trial-wear period. Blur thresholds were measured at 2 m with best spherical equivalent trial-frame correction for an array of 20/40 Sloan letters that were spatially fi ltered to simulate the superimposed blurred and clear images produced by a two-zone lens with a central 2 mm near addition (mean = +1.6D). From trial to trial, the relative contrast of the blurred and clear components of the image was varied. Subjects reported whether each image was clear, blurred but acceptable for performing everyday visual tasks, or blurred unacceptably.

RESULTS: Before CL fi tting, the mean blur-detection and blur-acceptance thresholds corresponded to relative contrasts of the blurred image (blurred-image contrast/clear-image contrast) of 0.51±0.06 (SE) and 1.80±0.61. After the trial-wear period, relative contrast thresholds were 0.52±0.04 and 1.70±0.30.

CONCLUSIONS: A 1-2 week period of wearing concentric simultaneous-vision contact lenses is not suffi cient to produce a statistically signifi cant reduction of perceived blur.

Pre-trial wear Post-trial wear

0.6

0.4

0.2

0

Co

ntra

st R

atio

(Blu

rred

imag

e/C

lear

imag

e)

BLUR DETECTION THRESHOLDS


Blur Adaptation with Simultaneous-Vision Contact Lenses

POSTEROCTOBER 13

#7

Harold E. Bedell, PhD, joined the University of Houston (UH) College of Optometry as an Assistant Professor in 1980. Previously, he received BS and MS degrees from Rensselaer Polytechnic Institute, a PhD from the University of Florida, and post-doctoral training at the University of California, Berkeley. He was named a UH John and Rebecca Moores professor in 2005. In 1999, he won the Glenn A. Fry award from the American Academy of Optometry for his research on interactions between visual perception and eye movements in persons with nystagmus. Dr. Bedell teaches courses in visual perception, eye movements and experimental methods. He received the outstanding graduate faculty teaching award at the UH College of Optometry ten times, the Cora and J. Davis Armistead faculty teaching award in 2007, and a UH teaching excellence award in 2011.


19

Magda Michna, PhDJohn Buch, OD, MS, FAAO

PURPOSE: Methods of classifying iris color available in the literature are often either based on subjective classifi cation of iris color, or describe quantitative methodology, but do not provide a visual scale for reference. The classifi cation of iris color is important for many reasons, including consistency in subjective iris color classifi cation, in genetic studies, and monitoring changes of iris color with reference to ocular conditions. The purpose of this work was to use a controlled method of image capture and quantitative analysis of color to create an iris color scale.

METHODS: Many factors must be considered when creating a scientifi cally robust iris color scale for use in subjective assessment of iris color, from image capture to printing. Methodologies for iris image capture were rigorously evaluated and optimized to ensure accurate color representation in the digital images. High resolution cameras and high quality optical lenses were used for image capture to ensure no artifacts were present, and camera exposure times and lighting intensities were also optimized to ensure accuracy and consistency. The color content of the resultant images was then analyzed using a methodology based on color representation schemes outlined by the Commission Internationale de l’éclairage (CIE), to ensure accurate color representation. The CIE L*a*b color space defi nes color based on human color perception, and is therefore the most appropriate for analysis of images that are to be used for subjective color assessment.

RESULTS: The CIE L*a*b color space was used to classify iris images not only by color, but also by lightness, allowing us to create a multi-category clinical iris color scale. The accurate production of the iris color scale on print substrates involved optimization of the color gamut using the properties of printing inks and paper refl ectance.

CONCLUSIONS: We present a novel, comprehensive methodology for creating an iris color scale using sophisticated image capturing methods and scientifi cally rigorous color analysis. This unique methodology has potential application in other medical fi elds.


Colors: Iris Color Scale Based on Quantitative Color Analysis

OCTOBER 13#12POSTER

Magda Michna, PhD, came to work for VISTAKON® Division of Johnson & Johnson Vision Care, Inc. in Jacksonville, Florida, over 3 1/2 years ago and is the clinical Vision Scientist in the Research & Development division. Dr. Michna received her PhD in optical physics from the University of Melbourne, and postdoctoral training at McGill University in the fi eld of human visual psychophysics. Dr. Michna has combined all of her previous academic research in her new role, where she is responsible for creating novel vision testing and clinical metrology, as well as conducting clinical trials.


20

Anna Sulley, BSc, MCOptom, FBCLA Graeme Young, OD, MPhil, PhD, FCOptom, DCLP, FAAO; Kathrine Osborn, OD, MS, FAAO, FBCLA; Chris Hunt, MSc

PURPOSE: To evaluate the ease with which non-users of toric soft contact lenses (CLs) can be fi tted with toric soft lenses.

METHODS: In this one month, multi-centre study, 200 astigmats in three categories were randomly assigned to be fi tted with one of two toric soft CLs featuring BLINK STABILIZEDTM Technology: etafi lcon A (1-DAY ACUVUE® MOIST® Brand Contact Lenses for ASTIGMATISM) or senofi lcon A (ACUVUE® OASYS® Brand Contact Lenses for ASTIGMATISM). The categories were i) spherical soft CL users, ii) lapsed CL wearers and iii) neophytes. As well as monitoring those successfully completing the study, pre-defi ned criteria for ‘success’ were set: acceptable fi t, stable orientation, binocular VA within one line of spectacle VA, and ‘good’ to ‘excellent’ comfort and vision quality.

RESULTS: Of the 200 subjects enrolled, 99% (198) were dispensed toric CLs of whom 92% (182/198) successfully completed the 1-month study. During fi tting, 88% (348/396) eyes were successfully fi tted on the fi rst attempt, and a further 12% (47/396) with two trial lenses. Based on the pre-defi ned criteria, the success rates were: 80%, 74% and 70% for the spherical CL wearer, CL drop-out and neophyte groups, respectively. Success was not predicted by sex, age, refractive state (myopia vs hyperopia), level of astigmatism (<1.50 vs 1.50DC), limbal hyperemia or corneal staining. For the spherical wearers, VA with toric CLs was signifi cantly better than with habitual spherical CLs (etafi lcon A: +0.06 vs +0.03 logMAR, senofi lcon A: +0.09 vs +0.01 logMAR, P<0.0001). There were no signifi cant diff erences in VA for the other groups.

CONCLUSION: The study has shown the relative ease with which astigmats can be successfully introduced to toric soft lenses.

Anna Sulley graduated from Aston University and spent several years in private practice before moving to Visioncare Research as a clinical investigator. She joined Hydron as International Clinical Manager in 1997 and then Johnson & Johnson Vision Care, Inc., in 2000 where she was Professional Aff airs Manager until 2004. After a few years dividing her time between private practice, medical writing, clinical research and consultancy to the contact lens industry, Anna returned to Johnson & Johnson in 2009 as Clinical Aff airs Manager for Europe, Middle East and Africa. Anna is Past President of the BCLA and was awarded BCLA Fellowship in 2006.

Study supported by Johnson & Johnson Vision Care, Inc.

POSTERHow Easy Is it to Fit Soft Toric Contact Lenses to Current Non-Users?

OCTOBER 14#38

Spectacles Wearers

CL DropOuts

Neophytes

Poorer VA

Bin

ocu

lar

VA

(lo

gM

AR

)

Better VA

.40

.30

.20

.10

.00

-.10

-.20

HABITUAL CORRECTIONSTUDY LENSES (4-WEEK)

P<0.001

100

90

80

70

60

50

40

30

20

10

0

Pro

po

rtio

n su

bje

cts

(%)

Overall Spherical CLwearers

Lapsedwearers

Neophytes

92 94 94

86


21

Prevalence of Sensitive Eyes in Contact Lens Wearers and the Eff ect of Refi tting with Silicone Hydrogel Lenses

* * * * * *

* * * *

60

50

40

30

20

10

0Diagnosed

Dryness

% o

f P

xs Q

ualif

ying

fo

r E

ach

Cri

teri

on

PREVALENCE OF KEY SIGNS/SYMPTOMS IN THE SE POPULATION (SEs VS. NO SEs)

Dryness (Dry or

Very Dry)

Dryness (Freq. or

Cons)

Redness(Freq. or

Cons)

Stinging(Freq. or

Cons)

Dryness,Redness, Stinging

3

2.5

2

1.5

1

0.5

0Dryness

REFITTING WITH SENOFILICON A LENSES DECREASED SIGNIFICANTLY THE FREQUENCY OF DRYNESS,

STINGING OR BURNING, REDNESS AND IRRITATION(BASELINE VS. FOLLOW UP RESULTS)

Sting or burn

AppearRed

Irritation

SIGNS AND SYMPTOMS*P<0.001

SYMPTOMS*P<0.001

Fre

que

ncy

of

Sym

pto

ms

Constantly

Never

All Pxs (N=2166SEs (n=265)Non-SEs (N=1901

Baseline (N=63)Follow-up (N=63)


OCTOBER 14#5POSTER

Sheila Hickson-Curran, BSc(Hons), MCOptom, FAAO, FBCLAMichael Spyridon, PhD; Chris Hunt, MSc; Graeme Young, OD, MPhil, PhD, FCOptom, DCLP, FAAO

PURPOSE: A proportion of contact lens (CL) wearers report ‘sensitive eyes’ (SE). The scale and the nature of this problem, however, are unclear.

To estimate the prevalence of SE in current soft CL wearers entering clinical trials and investigate the eff ect of refi tting SE-patients with senofi lcon A silicone hydrogel CLs.

METHODS: A database of 2166 current soft CL wearers aged between 18 and 45 years old, who defi ned as ‘normal’ as they entered the trials, was used to estimate the prevalence of ‘sensitive’ or ‘very sensitive eyes’. Approximately half of the SE patients were refi tted with senofi lcon A or other soft CLs, and reassessed 2 weeks later.

RESULTS: The prevalence of SE was 12.2% in soft CL wearers. SE correlated with dryness (P<0.0001), redness (P<0.0001) and stinging (P<0.0001), with 46% of the SE-patients experiencing one or more of these symptoms. Average comfortable wearing time was signifi cantly shorter in the SE population compared with non-SE patients (10.6 vs. 12.2 hours, P<0.001). No signifi cant associations were found between the prevalence of SE and clinical signs (limbal or bulbar hyperemia, corneal staining). Following refi tting with senofi lcon A, approximately 25% of the SE-subjects experienced signifi cant improvement in dryness (P<0.001). Limbal hyperemia (0.3 on a 0-4 scale, P<0.001), irritation (0.3 on a 0-3 scale, P=0.015) and stinging or burning (0.3 on a 0-3 scale, P=0.009) were also reduced in senofi lcon A fi tted SE-subjects.

CONCLUSIONS: Approximately one in eight soft CL wearers report SE and these patients are more likely to experience clinically signifi cant symptoms. The improvement in a number of these signs and symptoms following refi tting with senofi lcon A lenses suggests a potentially useful option for alleviating SE.

Sheila Hickson-Curran earned her optometry qualifi cations from the City University, London, United Kingdom. Sheila joined VISTAKON® in 1995 as a Research Optometrist, with positions of increasing responsibility in Research & Development. She is the co-inventor of BLINK STABILIZED™ Technology, used in ACUVUE® ADVANCE® for ASTIGMATISM and ACUVUE® OASYS® for ASTIGMATISM, for which she won a Johnson Medal, the highest award for innovation in Johnson & Johnson. In her role as Director of Medical Aff airs, she provides technical education for our professional customers, as well as professional insight and counsel for Brand teams. Sheila is a Fellow of the American Academy of Optometry.


22

Giovanna E. Olivares, OD, FAAOJordin Alford, MBA; Cristina Schnider, OD, MSc, MBA, FAAO

PURPOSE: This study examines the infl uence of practice setting & replacement recommendation on contact lens purchasing behavior in a large vision corrected population.

METHODS: 7500 vision corrected adults age 21-60 who had an eye exam and made a vision correction purchase (contact lens or spectacles) in the last 18 months participated in a 60-minute online survey regarding vision care practices. A subset of CL wearers were asked where they received their vision care, where they fi lled their prescriptions, and their recommended contact lens replacement frequency.

RESULTS:

• 1125 contact lens wearers obtained a prescription from private eye care professional and 630 from a retail-affi liated eye care professional. Of these, 611 contact lens wearers used a 2-week modality lens and 727 a monthly lens

• 1 in 5 patients purchase their CLs at a diff erent location regardless of whether they are fi t by a private or retail-affi liated eye care professional (P<0.05)

• 1 in 5 patients—whether in monthly or 2-week replacement lenses—purchase their contact lenses at a diff erent location regardless of whether they are fi t by a private or a retail-affi liated eye care professional (P<0.05)

• Only 1 in 10 patients purchased their CLs on the Internet

CONCLUSIONS: Neither the location of the exam (private or retail-affi liated) or prescribed replacement frequency impact the rate at which patients “walk” with their prescriptions. Further, only 1 in 10 report purchasing their CLs on the internet. Future analysis of the data will look at factors that may infl uence patient decision making in the purchase of their contact lens.


POSTERContact Lens Purchase Behavior: Impact of Practice Setting & Modality

OCTOBER 14#24

Dr. Olivares is the Director of Professional Education at VISTAKON® Division of Johnson & Johnson Vision Care, Inc. In this role, she is responsible for the development of new and innovative educational professional programs. Dr. Olivares graduated from the State University of New York with a doctorate degree and subsequently completed a post-doctoral fellowship program in ocular disease management in affi liation at the State University of New York College of Optometry. Upon completion of her fellowship, she became an Assistant Professor at the College of Optometry having responsibility in both didactic and clinical programs. Following her academic career, she joined Unilens Corp. USA as the Director of Professional Development and Clinical Aff airs, and spent 12 years developing new presbyopic contact lenses. In 2004 she joined VISTAKON®. As the Senior Manager of Clinical Research she led a multidisciplinary group of optometrists, biostatisticians, and vision scientists that were responsible for the development of new contact lens products such as ACUVUE® ADVANCE® for ASTIGMATISM, ACUVUE® OASYS® Brand Contact Lenses for ASTIGMATISM, ACUVUE® ADVANCE® Plus, and other products that have been launched throughout the world. Dr. Olivares is a Fellow of the American Academy of Optometry.


Reference: 1. Data on fi le. Johnson & Johnson Vision Care, Inc. 2009.

ACUVUE® Brand Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from VISTAKON® Division of Johnson & Johnson Vision Care, Inc., by calling 1-800-843-2020 or by visiting jnjvisioncare.com.

1-DAY ACUVUE® MOIST®, LACREON®, INNOVATION FOR HEALTHY VISION™, and VISTAKON® are trademarks of Johnson & Johnson Vision Care, Inc.

*All third-party products are trademarks of their respective companies.

© Johnson & Johnson Vision Care, Inc. 2011. August 2011

1-DAY ACUVUE® MOIST® Brand Contact Lenses with LACREON® Technology

Because satisfi ed patients lead to successful practicesHow many of your reusable contact lens patients are experiencing dryness? The uncomfortable truth is that many may be. Keep patients satisfi ed and eyes comfortable with the unsurpassed overall comfort of 1-DAY ACUVUE® MOIST® Brand1:

• In a clinical study, 1-DAY ACUVUE® MOIST® wearers rated the brand superior to DAILIES®* AQUA COMFORT PLUS®* in feeling as comfortable at the end of the day as the beginning and feeling smooth on eyes all of the time1

INNOVATION FOR HEALTHY VISION™



ACUVUE®, 1-DAY ACUVUE® TruEye™, 1-DAY ACUVUE® MOIST®, ACUVUE® OASYS®, ACUVUE® ADVANCE®, HYDRACLEAR®, LACREON®, INNOVATION FOR HEALTHY VISION™, and VISTAKON® are trademarks of Johnson & Johnson Vision Care, Inc.



Because satisfied patients lead to successful practices

ACUVUE® Brand Contact Lenses

are at the forefront of innovation

because we constantly strive to

deliver lenses that provide the kind

of comfort your patients can feel

and health you can see.


26

Dear Colleagues,

Having grown up in Oregon, where the skies are often gray, it may seem odd that one of my professional passions involves UV protection. But what I have learned in recent years about the subject has reinforced the relevance of the topic, and the need for early and frequent education of our patients on the importance of UV protection.

In late 2010, a group of 13 internationally renowned authorities on the eff ects of UV radiation on the eye gathered in Las Vegas. This symposium was sponsored by the Eye & Contact Lens Journal and the Contact Lens Association of Ophthalmologists, and the fi ndings were published in the July 2011 issue of Eye & Contact Lens. My key takeaway is that we need to do more to educate our colleagues on the opportunity to deliver value to our patients through providing information and options to protect their eyes from UV damage.†

Here are a couple “fun facts” about UV and the eye from the July 2011 issue of Eye & Contact Lens:

• Due to the unique anatomy of the eye and the earth’s orbit, the peak exposure on a late summer day for the eyes is actually around 9:00 am and 2:00-3:00 pm, versus noon when the sun is at the top of the head and eyes are actually shaded by the brow ridge. The main thing to remember is that when the sun is below an angle of about 40 degrees from the horizon, the eyes are being directly exposed

• Light that enters the eye through the temporal periphery of the cornea is actually concentrated by the optics of the eye on the nasal side, off ering a possible explanation for the nasal predilection of certain UV-related eye diseases such as cortical cataract

• In addition to wearing shading headwear and well designed and fi tted sunglasses, wearing UV-blocking contact lenses that cover the limbus provide additional protection from all sources of UV radiation incident on the cornea and limbus, whether directed, refl ected or refracted†

You are invited to pick up a reprint of the entire journal at our conference booth, or email us at [email protected]. In the meantime, I hope I have whet your appetite for relating this important topic to your patients.

Best Regards,

Cristina M Schnider, OD, MSc, MBA, FAAOSenior Director, Medical Aff airsVISTAKON® Division of Johnson & Johnson Vision Care, Inc.

Cristina M Schnider, OD, MSc, MBA, FAAO

References: Sasaki H, et al. UV-B exposure to the eye depending on solar altitude. Eye & Contact Lens. 2011;37(4):191-195.Coroneo M. Ultraviolet radiation and the anterior eye. Eye & Contact Lens. 2011;37(4):214-224.Walsh J, Bergmanson J. Does the eye benefi t from wearing ultraviolet-blocking contact lenses? Eye & Contact Lens. 2011;37(4):267-272.


Reference: 1. Data on fi le. Johnson & Johnson Vision Care, Inc. 2008.


ACUVUE® OASYS®, BLINK STABILIZED™, HYDRACLEAR®, INNOVATION FOR HEALTHY VISION™, and VISTAKON® are trademarks of Johnson & Johnson Vision Care, Inc.


ACUVUE® OASYS® Brand Contact Lenses for ASTIGMATISM with BLINK STABILIZEDTM Technology

Because satisfi ed patients lead to successful practicesDo your monthly astigmats experience visual blur too often? The uncomfortable truth is they may. Satisfy your patients with the only lens designed to work solely with the blink1—2-week ACUVUE® OASYS® Brand for ASTIGMATISM with BLINK STABILIZED™ Technology. For more consistent, clear, stable vision regardless of head or eye position.

INNOVATION FOR HEALTHY VISION™INNONOVAVATITIONON FFOROR HHEAEALTLTHYHY VVISISIOIONN™


References: 1. Data on fi le. Johnson & Johnson Vision Care, Inc. 2009. 2. Data on fi le. Johnson & Johnson Vision Care, Inc. 2008.


ACUVUE® OASYS®, HYDRACLEAR®, INNOVATION FOR HEALTHY VISION™, and VISTAKON® are trademarks of Johnson & Johnson Vision Care, Inc.

*All third-party products are trademarks of their respective companies.


ACUVUE® OASYS® Brand Contact Lenses with HYDRACLEAR® Plus Technology

INNOVATION FOR HEALTHY VISION™

Because satisfi ed patients lead to successful practicesAre your monthly patients experiencing dryness during the 3rd or 4th week of wear? The uncomfortable truth is they may be. Satisfy your patients with 2-week ACUVUE® OASYS® Brand:

• Superior comfort across the 2-week wear cycle versus AIR OPTIX®* AQUA and Biofi nity®* in 2 separate head-to-head studies1,2


VISTAKON® is proud to have partnered with the American Optometric Foundation for over a decade, providing over onemillion dollars of support for scholarships, fellowships, and research grants.

VISTAKON® Ezell Fellows 2005-20102005 Danielle Robertson University of Houston

2005 Ling Chi Huang University of Houston

2006 Jose Capo-Aponte State University of New York

2006 Johannes Burge University of California, Berkeley

2007 Zan Pan State University of New York

2007 Rachel Redfern University of Houston

2008 Joe Phillips University of Houston

2008 Lakshman Subbaraman University of Waterloo

2009 Eric Ritchey The Ohio State University

2009 Vidhyapriya Sreenivasan University of Waterloo

2010 Nicole Putnam, MS University of California, Berkeley

2010 Johanna Tukler- University of Houston Henriksson, BS

VISTAKON® Research Grant Recipients 2005-20102005 $25,000 Joseph A. Bonanno Indiana University Tear Oxygen Tension beneath Silicone Hydrogel Contact Lenses

2005 $10,000 Barbara A. Fink The Ohio State University Contributions of Silicone Hydrogel Lens Thickness, Lens Permeability, and Tear Exchange to Corneal Oxygen Supply

2006 $25,000 Alison McDermott University of Houston Antimicrobial Contact Lenses

2006 $10,000 Lyndon Jones University of Waterloo School of Optometry A Novel Method to Quantify Protein Adsorption and Absorption on Hydrogel Contact Lenses Using Confocal Microscopy

2007 $25,000 Nancy Keir University of Waterloo School of Optometry Investigation of the Optical Performance of Silicone Hydrogel Contact Lenses

2007 $10,000 Ewen King-Smith The Ohio State University The Relation of Pre-Lens Tear Film Thinning to the Thickness and Distribution of the Lipid Layer

2008 $25,000 Danielle M. Robertson University of Texas Southwestern Medical School The Role of the Post Lens Tear Film in Lipid Raft-mediated Pseudomonas Internalization

2008 $25,000 H. Dwight Cavanagh University of Texas Southwestern Medical School The Role of the Post Lens Tear Film in Lipid Raft-mediated Pseudomonas Internalization

2008 $10,000 Lyndon Jones University of Waterloo School of Optometry The Impact of Rub & No-Rub Care Products on Protein Removal and Localization

2008 $10,000 Doerte Luensmann University of Waterloo School of Optometry The Impact of Rub & No-Rub Care Products on Protein Removal and Localization

2009 $25,000 Frank Anasrasopoulos/Carol Lakkis Victorian College of Optometry The Eff ect of Contact Lens Materials on Expression of Pseudomonas Aeruginosa Virulence Factors

2009 $10,000 Blanka Golebiowski/Isabelle Jalbert University of New South Wales Nerves and Neuropeptides in Contact Lens Related Dry Eye

2010 $25,000 Loretta Szczotka-Flynn, OD, PhD/IIene Gipson, PhD Harvard Medical School Uncovering the Role of Mucins in Contact Lens Induced Corneal Infi ltrates

2010 $10,000 Alex Hul, OD/David McCanna, BSc, MA, PhD University of Waterloo School of Optometry Engineering of Novel Contact Lens Materials for Ciprofl oxacin

The recipients of the 2011 AOF VISTAKON® Award of Excellence are:Lindsey Barouh Pennsylvania College of Optometry

Joseph Conrad The Ohio State University

Brittany Nelson Pacifi c University College of Optometry

Katherine Paulsen Southern College of Optometry

Katie Wicks University of Houston

Veronica Woi Southern California College of Optometry

Yin-Yin Aung New England College of Optometry

Sheila Morris University of Alabama at Birmingham

Brian Paul, OD Nova Southeastern University

Dana Pollack State University of New York

Tanya Polonenko University of Waterloo

Stefanie Ratermann Illinois College of Optometry

Pam Satjawatcharaphong University of California, Berkeley

Richard Wardé University of Montreal

Derek Wiles University of Missouri, St. Louis

Lauren Quaine Michigan College of Optometry

Colby Fletcher, OD Indiana University

Charlie C. Dao, OD Puerto Rico School of Optometry

Natalie Pham, OD Northeastern State University Oklahoma College of Optometry

2011 George W. Mertz Contact Lens Residency AwardLindsay Sicks, OD Norfolk State University

Chris Kenrick, OD New England College of Optometry

2011 Sheldon Wechsler Contact Lens Residency AwardsSteven J. Warne, OD University of Alabama at Birmingham

Michael Rebarchik, OD New England College of Optometry

2011 Terrance Ingraham Pediatric Optometry Residency AwardsJenelle L. Mallios, OD New England College of Optometry

Yos M. Priestley, OD New England College of Optometry

For further information, contact:Tracy KittsFoundation CoordinatorAmerican Optometric Foundation(301) [email protected]

The recipients of the 2011 VISTAKON® Ezell Fellowships are:

Tatiana Ecoiffi er, MEng, MSUniversity of California Berkeley School of Optometry

Kristina Haworth, BBA, OD, MS, FAAOUniversity of Houston College of Optometry

Each will receive $8,000 toward their graduate education and $3,000 travel grants to the annual meetings of the American Academy of Optometry and the Association for Research in Vision and Ophthalmology.

VISTAKON®, American Optometric Foundation Fellowship and Grant Recipients


30

In a recent survey of reusable lens wearers…

WITHOUT ACUMINDER™:

42% of patients were compliant with their wear schedule2

WITH ACUMINDER™:

77% of patients were compliant with their wear schedule2

THE ONLY CONTACT LENS REMINDER TOOL PROVEN TO INCREASE PATIENT COMPLIANCE

THE ACUMINDER™ TOOL

ACUMINDER™ makes patient compliance easier.

References: 1. Dumbleton K, Woods C, Jones L, Fonn D, Sarwer DB. Eye & Contact Lens. 2009;35:164-171. 2. Data on file. Johnson & Johnson Vision Care, Inc. 2010.

ACUMINDER™ is a trademark of Johnson & Johnson Vision Care, Inc.

© Johnson & Johnson Vision Care, Inc. 2011. 2011

Help patients stay on schedule and in your practice—patients join free at ACUMINDER.COM

The #1 reason patients overwear their contact lenses is forgetfulness1Th #1

FA C T :


31

We believe our fi rst responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services.In meeting their needs everything we do must be of high quality.We must constantly strive to reduce our costs in order to maintain reasonable prices. Customers’ orders must be serviced promptly and accurately.Our suppliers and distributors must have an opportunity to make a fair profi t.

We are responsible to our employees, the men and women who work with us throughout the world. Everyone must be considered as an individual.We must respect their dignity and recognize their merit. They must have a sense of security in their jobs. Compensation must be fair and adequate, and working conditions clean, orderly and safe. We must be mindful of ways to help our employees fulfi ll their family responsibilities. Employees must feel free to make suggestions and complaints. There must be equal opportunity for employment, development and advancement for those qualifi ed. We must provide competent management, and their actions must be just and ethical.

We are responsible to the communities in which we live and work and to the world community as well. We must be good citizens — support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources.

Our fi nal responsibility is to our stockholders. Business must make a sound profi t.We must experiment with new ideas. Research must be carried on, innovative programs developed and mistakes paid for. New equipment must be purchased, new facilities provided and new products launched. Reserves must be created to provide for adverse times. When we operate according to these principles, the stockholders should realize a fair return.

OUR CREDO



†Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

ACUVUE® ADVANCE® Brand Contact Lenses for ASTIGMATISM block greater than 90% of UV-A rays and 99% of UV-B rays.

ACUVUE® OASYS® Brand Contact Lenses for ASTIGMATISM block greater than 90% of UV-A rays and 99% of UV-B rays.

ACUVUE® Brand Contact Lenses block greater than 82% of UV-A rays and 97% of UV-B rays.

ACUVUE®, 1-DAY ACUVUE® MOIST®, ACUVUE® ADVANCE®, ACUVUE® OASYS®, 1-DAY ACUVUE® TruEyeTM, HYDRACLEAR®, ULTRA-CLEAN™, BLINK STABILIZED™, LACREON®, ACUMINDER™, CLUE: Contact Lens User ExperienceTM, PUPIL INTELLIGENT DESIGN™, STEREO PRECISION TECHNOLOGY™, INNOVATION FOR HEALTHY VISIONTM, and VISTAKON® are trademarks of Johnson & Johnson Vision Care, Inc.

ODLeanTM and THE VISION CARE INSTITUTETM are trademarks of THE VISION CARE INSTITUTETM, LLC.

*All third-party trademarks are owned by their respective companies.

© Johnson & Johnson Vision Care, Inc. 2011. August 2011.


guia de boston inglés

Documents

hydraclear technology

hydraclear plus

enhanced technology

exceptional comfort

vision care institute

disposable silicone

stable lens

am4the worlds